Company Profile

Innovative Pharmaceutical Biotech Limited ("IPB") has two primary segments of business: the research and development of pharmaceutical products and trading of beauty equipment and products. Currently, IPB is focused on developing an insulin product that could be administered orally. The company is keen to expand its research and development segment by acquiring additional pharmaceutical products with commercial viability.

IPB was formerly known as United Gene High-Tech Group Limited and focused on genetic testing, healthcare management and the distribution of bio-industrial products.

The shares of IPB are listed on the Main Board of the Hong Kong Stock Exchange under the code 399.